
Carlsmed Inc (CARL) Stock Forecast & Price Target
Carlsmed Inc (CARL) Analyst Ratings
Bulls say
Carlsmed is a rapidly growing medical technology company with a unique AI-enabled platform and increasing surgeon adoption, leading to potential revenue growth. With reported positive clinical outcomes and a strong focus on profitability, this company is expected to continue its double-digit growth trajectory. However, changes in reimbursement and competition may have an impact on their stock price.
Bears say
Carlsmed is a medical technology company specializing in personalized solutions for spine surgery, but its lack of profitability and reliance on Medicare as its primary payer could hinder its growth potential. While its aprevo technology has shown promise for improving patient outcomes and surgical efficiency, there is competition in the market and Carlsmed's limited patent protection may leave it vulnerable. Furthermore, despite potential upside from surgeon adoption and reimbursement changes, it remains to be seen if Carlsmed can reach profitability with its current projected revenue and spending.
This aggregate rating is based on analysts' research of Carlsmed Inc and is not a guaranteed prediction by Public.com or investment advice.
Carlsmed Inc (CARL) Analyst Forecast & Price Prediction
Start investing in Carlsmed Inc (CARL)
Order type
Buy in
Order amount
Est. shares
0 shares